Navigation Links
Drug Could Make Melanoma More Vulnerable to Chemo
Date:3/6/2009

Compound disabled protein fueling tumor growth, making therapy more effective

FRIDAY, March 6 (HealthDay News) -- A compound that targets and disables a protein found in melanoma tumors may make the deadly skin cancer more vulnerable to chemotherapy, early results of a pilot study show.

Sixteen patients with advanced melanoma on an extremity (feet, hands, etc.) were given the compound ADH-1 intravenously and then underwent chemotherapy by infusion in the affected limb. The melanoma was eradicated in half the patients.

The findings were expected to be presented Friday at the Society of Surgical Oncology annual meeting in Phoenix, and have been accepted for publication in the journal Cancer. The study was funded by Adherex Technologies, which is developing ADH-1.

"These early results are very exciting, because metastatic melanoma is one of the most deadly cancers and one which is typically very unresponsive to therapy," lead author Dr. Georgina Beasley, a surgical resident at the Duke Comprehensive Cancer Center, said in a university news release. "The next step will be to continue testing the efficacy of this treatment in more patients, here and at other centers."

A Phase II trial involving 46 patients has recently completed recruiting participants.

The incidence of melanoma is increasing at a rate faster than any other cancer, and 60,000 new cases of melanoma will be diagnosed in the United States this year, according to background information in the news release.

Melanoma often develops on extremities, and up to 10 percent of patients with extremity melanoma develop multiple recurrences that can't be treated with surgery alone. Melanoma that spreads beyond the primary site is rarely curable, and there are limited treatment options.

More information

The American Academy of Dermatology has more about melanoma.



-- Robert Preidt



SOURCE: Duke Medicine, news release, March 6, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Number of cardiovascular risk factors could determine safety of intravenous gammaglobulin treatment
2. Engineered Viruses Could Battle Superbugs
3. Stem cells could halt osteoporosis, promote bone growth
4. TB breakthrough could lead to stronger vaccine
5. Classifying concussions could help kids
6. Vegetable-based drug could inhibit melanoma
7. Report: Many Cancers Could Be Prevented in US
8. Landmark Policy Report: Many Cancers Could Be Prevented Across the Globe
9. Landmark Report: Many Cancers Could be Prevented
10. Economy could reduce colorectal cancer screening rate
11. UCSF Gallo Study Finds Hormone Disorder Drug Could Help Drinkers Stay Sober
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Could Make Melanoma More Vulnerable to Chemo
(Date:3/24/2017)... ... March 24, 2017 , ... ... stories about real people of God in congregations across the United States. ... Presbyterian minister ordained in 1964 who has served congregations in seven states throughout ...
(Date:3/23/2017)... Greensboro, NC & Seattle, WA (PRWEB) , ... March 23, 2017 ... ... international public health emergency and now estimates that there could be four million Zika-related ... fastest growing epidemics to date with numbers of US cases reported per year skyrocketing ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The physicians ... location in the greater Houston Area. The new location is located at 2255 E. ... Hospital in Springwoods Village. This newest location will provide patients living in the north ...
(Date:3/23/2017)... TX (PRWEB) , ... March 23, 2017 , ... ... clinic, located at 960 Gruene Road in Building 2. The clinic is the group’s ... Andrew Bennett, PT, says opening the company’s second New Braunfels location brings things full ...
(Date:3/23/2017)... Minneapolis, MN (PRWEB) , ... March 23, 2017 , ... ... with internet and WiFi connectivity are making a huge impact on businesses and individual ... Global Institute estimates the IoT will have a value anywhere from $4 trillion to ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... 23, 2017  Mirabilis Medical, a ... for non-invasive surgery, announced today CE Mark authorization ... of uterine fibroids throughout the European Union.  The ... from the US Food and Drug Administration to ... in the United States.  The Mirabilis System combines ...
(Date:3/23/2017)... Research and Markets has announced the addition ... Forecast to 2025" report to their offering. ... The Global Cryostat Market is ... next decade to reach approximately $3.5 billion by 2025. ... the given segments on global as well as regional levels presented ...
(Date:3/23/2017)... 23, 2017  Transportation Insight, a multi-modal lead logistics ... chain management firm with expertise serving clients in the ... Rick Zaffarano was named a 2017 Food ... by the only publication exclusively dedicated to covering the ... "Rick has brought to Transportation Insight a ...
Breaking Medicine Technology: